Mobile

Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy

Mise à jour : Il y a 4 ans
Référence : NCT00908349

Femme et Homme

Extrait

Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Oxcarbazepine Extended-Release (OXC XR)

Critère d'inclusion

  • Partial epilepsy

Liens